According to a new report Global Cancer Immunotherapy Market, published by KBV research, The Global Cancer Immunotherapy Market size is expected to reach $128.3 billion by 2024, rising at a market growth of 14.3% CAGR during the forecast period.
The US market would dominate the North America Cancer Immunotherapy Colorectal Cancer Market by 2024; growing at a CAGR of 11.4 % during the forecast period. The Canada market is expected to witness a CAGR of 14% during (2018 - 2024). Additionally, The Mexico market is expected to witness a CAGR of 13.3% during (2018 - 2024).
The Monoclonal Antibodies market dominated the Global Cancer Immunotherapy Market by Technology 2017, thereby, achieving a market value of $61,048.9 million by 2024. The Cytokines & Immunomodulators market is expected to witness a CAGR of 12.8% during (2018 - 2024). Additionally, The Other Technology market is expected to witness highest CAGR of 15.2% during (2018 - 2024).
The Lung Cancer market dominated the Global Cancer Immunotherapy Market by Application 2017, growing at a CAGR of 13 % during the forecast period. The Melanoma market is expected to witness a CAGR of 16% during (2018 - 2024). Additionally, The Head & Neck Cancer market is expected to witness highest CAGR of 14.9% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/cancer-immunotherapy-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd
By Technology
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
North America Cancer Immunotherapy Market (2018-2024)
Europe Cancer Immunotherapy Market (2018-2024)
Unique Offerings 
